The main cause of insulin resistance is excess fat stored in places it doesn’t belong, particularly inside the liver and muscle cells. While genetics, inflammation, poor sleep, and inactivity all play roles, the accumulation of fat droplets within organs that aren’t designed to store large amounts of fat is the central driver that disrupts insulin’s ability to do its job.
To understand why, it helps to know what insulin resistance actually looks like at the cellular level and what pushes the body toward it.
How Fat in the Wrong Places Blocks Insulin
Your body stores most of its fat in dedicated fat tissue under the skin. That’s normal and healthy. Problems start when excess calories cause fat to spill over into organs like the liver and into skeletal muscle, a process called ectopic fat accumulation. Once fat builds up in these tissues, it generates byproducts that physically interfere with insulin signaling inside cells.
In the liver, the key culprit is a fat byproduct called diacylglycerol. When diacylglycerol accumulates in liver cells, it activates an enzyme that essentially blocks the insulin receptor from passing its message along. Think of it like jamming a lock: insulin arrives at the cell’s door, but the internal machinery needed to open that door gets switched off. Research published through the American Heart Association found that in humans, elevated diacylglycerol in the liver and the resulting enzyme activation are the factors most strongly associated with liver-specific insulin resistance.
A second pathway involves saturated fatty acids triggering inflammatory signaling inside cells. This leads to the production of ceramides, waxy fat molecules that block a different step in insulin’s chain of command. On top of that, unprocessed fats in the liver can stress the cell’s internal recycling machinery (the endoplasmic reticulum), activating inflammatory pathways that further suppress insulin signaling and increase production of inflammatory molecules. These overlapping mechanisms help explain why fatty liver disease and insulin resistance so often travel together.
The Role of Belly Fat and Inflammation
Visceral fat, the deep abdominal fat surrounding your organs, contributes to insulin resistance through a different route: chronic, low-grade inflammation. Fat tissue isn’t just passive storage. It’s metabolically active, and visceral fat in particular pumps out inflammatory signaling molecules that circulate throughout the body.
The connection between inflammation and insulin resistance was first established when researchers found that a specific inflammatory molecule, TNF-alpha, directly promoted insulin resistance in fat tissue, and that neutralizing it improved glucose sensitivity in animal models. Since then, studies have identified additional inflammatory signals, including IL-6 and IL-1 beta, that are elevated in people with type 2 diabetes. A large prospective study of 27,000 people found that circulating IL-6, when present alongside detectable IL-1 beta, independently predicted the development of type 2 diabetes.
The relationship is strong enough that blocking these inflammatory signals can measurably improve insulin sensitivity. In patients with rheumatoid arthritis, for example, treatments that inhibit IL-1 beta signaling have been shown to reduce insulin resistance as a secondary benefit. That said, the picture isn’t perfectly simple. Research on obese patients undergoing bariatric surgery found that a significant proportion of obese individuals did not express TNF-alpha, IL-1 beta, or IL-6 in their visceral fat tissue at all, suggesting that obesity-related inflammation varies considerably from person to person.
Mitochondrial Stress and Oxidative Damage
Inside every cell, mitochondria convert food into energy. This process naturally produces small amounts of reactive oxygen species, sometimes called free radicals. In a healthy body, these are managed without issue. But in conditions of excess energy supply, like obesity or consistently high caloric intake, mitochondria become overloaded and generate excessive free radicals.
This oxidative stress activates the same protein signaling pathways that suppress insulin’s message at the cellular level, contributing to resistance. The inflammatory environment created by visceral fat compounds the problem, creating a feedback loop: more fat leads to more inflammation, which leads to more mitochondrial stress, which leads to worse insulin signaling. Over time, this chronic oxidative burden is thought to be one of the mechanisms that pushes insulin resistance from a temporary metabolic hiccup into a lasting condition.
Sleep, Stress, and Inactivity
Several lifestyle factors can worsen insulin resistance independently of body fat. Sleep deprivation is one of the most potent. A study from the American Diabetes Association found that limiting healthy men to five hours of sleep per night for just one week reduced insulin sensitivity by 20% on average. That’s a significant metabolic shift from sleep loss alone, without any change in diet or weight.
Chronic stress contributes through elevated cortisol, which raises blood sugar and promotes visceral fat storage. Sedentary behavior matters too, because skeletal muscle is the largest consumer of blood sugar in the body, and inactive muscles become less responsive to insulin over time.
Exercise, on the other hand, is one of the most effective tools against insulin resistance, and part of the reason is that it works through a completely separate pathway from insulin. During and after physical activity, muscles pull glucose out of the bloodstream without needing insulin at all. After exercise, an energy-sensing system in muscle cells promotes the movement of glucose transporters to the cell surface, allowing muscles to continue absorbing glucose at elevated rates during recovery. This is why a single bout of exercise can lower blood sugar for hours afterward, and why regular physical activity consistently improves insulin sensitivity even before any weight is lost.
Genetics and Individual Variation
Some people develop insulin resistance more easily than others, and genetics play a real but secondary role. Research has identified defects in how cells transport glucose internally. In insulin-resistant individuals, the glucose transporter proteins that are supposed to move to the cell surface when insulin arrives get stuck in a dense internal compartment, unable to reach their destination. This trafficking defect has been observed in both muscle and fat cells and appears to be a shared feature of insulin resistance whether or not someone has diabetes.
Interestingly, fat tissue also regulates insulin sensitivity through glucose processing pathways. The level of a specific gene regulator activated by glucose in fat cells has been shown to predict whole-body insulin sensitivity in humans. People whose fat tissue processes glucose more efficiently tend to be more insulin sensitive overall, regardless of how much fat they carry.
That said, large genetic screens have found that specific mutations in the glucose transporter gene itself are rare and not clearly linked to diabetes risk in the general population. Genetics likely influence insulin resistance more through broad traits, like where your body tends to store fat, how your liver handles lipids, and how readily your fat tissue becomes inflamed, rather than through a single gene defect.
How Insulin Resistance Is Measured
The most common clinical tool for estimating insulin resistance is the HOMA-IR score, calculated from fasting blood sugar and fasting insulin levels. A score of 2.5 or above is the most widely used threshold for identifying insulin resistance in the general population, though the European Group for the Study of Insulin Resistance uses a lower cutoff of 2.0. There is no universally agreed-upon number, and the ideal cutoff may vary by sex, ethnicity, and underlying conditions.
Because insulin resistance develops gradually and often produces no obvious symptoms for years, many people have it without knowing. The earliest signs tend to be subtle: rising fasting blood sugar, increasing waist circumference, higher triglycerides, and lower HDL cholesterol. These metabolic shifts often appear years before blood sugar climbs high enough to be classified as prediabetes or diabetes.